A team of Pillsbury lawyers advised InnFocus Inc., a developer of a glaucoma-treatment device, in its sale to Santen Pharmaceutical Co., a specialty eye care provider. The purchaser will pay $225 million upfront, with additional payments contingent upon the achievement of performance-based development, regulatory and commercial benchmarks.

Silicon Valley corporate partner Tom Thomas led the Pillsbury team advising InnFocus. The team also included Corporate & Securities – Tech partner Thomas Chaffin, Executive Compensation & Benefits partner Daniel Stellenberg, Tax partner Brian Wainwright, Environmental senior counsel Chuca Meyer and associates Ryan Delaney, Evan Lee, Anna He, Matthew Ryan, Julie Park and Gabrielle Grinberg.